Jazz Pharmaceuticals Plc (JAZZ)
241.55
+1.18
(+0.49%)
USD |
NASDAQ |
Nov 13, 16:00
241.57
+0.02
(+0.01%)
Pre-Market: 19:59
Jazz Pharmaceuticals EPS Diluted (Quarterly) : -7.471 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -7.471 |
| June 30, 2026 | 2.778 |
| March 31, 2026 | 4.434 |
| December 31, 2025 | 3.207 |
| September 30, 2025 | 4.081 |
| June 30, 2025 | -11.74 |
| March 31, 2025 | -1.518 |
| December 31, 2024 | 3.107 |
| September 30, 2024 | 3.404 |
| June 30, 2024 | 2.421 |
| March 31, 2024 | -0.2338 |
| December 31, 2023 | 1.351 |
| September 30, 2023 | 2.059 |
| June 30, 2023 | 1.420 |
| March 31, 2023 | 0.941 |
| December 31, 2022 | -3.818 |
| September 30, 2022 | -0.3129 |
| June 30, 2022 | 0.5465 |
| March 31, 2022 | 0.0262 |
| December 31, 2021 | -0.5748 |
| September 30, 2021 | -0.8621 |
| June 30, 2021 | -6.112 |
| March 31, 2021 | 2.086 |
| December 31, 2020 | 2.334 |
| September 30, 2020 | 2.636 |
| Date | Value |
|---|---|
| June 30, 2020 | 2.055 |
| March 31, 2020 | -2.821 |
| December 31, 2019 | 1.292 |
| September 30, 2019 | 1.781 |
| June 30, 2019 | 4.560 |
| March 31, 2019 | 1.467 |
| December 31, 2018 | 2.640 |
| September 30, 2018 | 2.414 |
| June 30, 2018 | 1.50 |
| March 31, 2018 | 0.7518 |
| December 31, 2017 | 3.79 |
| September 30, 2017 | 1.03 |
| June 30, 2017 | 1.72 |
| March 31, 2017 | 1.41 |
| December 31, 2016 | 1.91 |
| September 30, 2016 | 1.45 |
| June 30, 2016 | 1.85 |
| March 31, 2016 | 1.21 |
| December 31, 2015 | 1.32 |
| September 30, 2015 | 1.39 |
| June 30, 2015 | 1.40 |
| March 31, 2015 | 1.12 |
| December 31, 2014 | 1.30 |
| September 30, 2014 | 0.41 |
| June 30, 2014 | 0.70 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 0.0002 |
| GH Research Plc | -0.2276 |
| Cosmo NV | -- |
| Corcept Therapeutics, Inc. | 1.010 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -483.40M |
| Revenue (Quarterly) | 1.243B |
| Total Expenses (Quarterly) | 1.726B |
| Enterprise Value | 18.27B |
| Gross Profit Margin (Quarterly) | 77.28% |
| Profit Margin (Quarterly) | -38.89% |
| Earnings Yield | 1.22% |
| Operating Earnings Yield | 7.34% |
| Normalized Earnings Yield | 5.124 |